Ju Guo

6PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersEnvironmental biogeochemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 29, 2026
CXCR2-mediated metabolic interaction between prostate cancer cells and the immunosuppressive tumor microenvironment.

|May 29, 2026
Ferroptosis vulnerability of enzalutamide resistant prostate cancer conferred by ACSL4 overexpression and GPX4 antagonism.

|Apr 20, 2026
Zinc-dependent Zip7-MAZ-MYBL2 axis promotes prostate cancer metastasis.

|Mar 24, 2026
Non-classic deubiquitinase USP13 inhibits bladder cancer metastasis through destabilizing cytoplasmic KDM3A.

Hongji Hu, Xiangpeng Zhan, Yunqiang Xiong

|Jul 30, 2025
Retraction Note: Non-classic deubiquitinase USP13 inhibits bladder cancer metastasis through destabilizing cytoplasmic KDM3A.

Hongji Hu, Xiangpeng Zhan, Yunqiang Xiong

|Apr 19, 2025
Non-classic deubiquitinase USP13 inhibits bladder cancer metastasis through destabilizing cytoplasmic KDM3A.

Hongji Hu, Xiangpeng Zhan, Yunqiang Xiong

Pageof 1

Frequent Collaborators

3 joint publications

Songhui Xu

1 joint publications

Bin Fu

1 joint publications

Songhui Xu

1 joint publications

Yifan Zhang